Astragaloside IV alleviates inflammation and improves myocardial metabolism in heart failure mice with preserved ejection fraction

BackgroundHeart failure with preserved ejection fraction (HFpEF) has grown to become the dominant form of heart failure worldwide. However, no unequivocally effective treatment for HFpEF has been identified in clinical trials. In this study, we report that Astragaloside IV (AS-IV) can be used to tre...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Xiao Wang, Xinting Chen, Yuting Wang, Xinyu He, Lan Li, Xiaodan Wang, Yuting Huang, Guanwei Fan, Jingyu Ni
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Frontiers Media S.A. 2024-11-01
Cyfres:	Frontiers in Pharmacology
Pynciau:	HFpEF astragaloside IV inflammation metabolism mitochondria
Mynediad Ar-lein:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1467132/full
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!